3 completed. 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Elixir Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Delayed-release Bedtime Caffeine and Sleep Inertia Symptoms Immediately Upon Awakening Caffeine, Placebo - Sleep Inertia, Caffeine | Not applicable | Completed | University of Zurich | 32 | 2019-02-08 | 2021-07-29 |
| Drug-Drug Interaction Study of Mitiglinide and Gemfibrozil placebo for gemfibrozil, gemfibrozil - Type 2 Diabetes Mellitus | Phase 1 | Completed | Elixir Pharmaceuticals | 14 | 2007-11-01 | 2009-02-18 |
| Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus placebo for mitiglinide, mitiglinide - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Elixir Pharmaceuticals | 367 | 2007-08-01 | 2009-09-17 |
Diabetes Mellitus, Type 2 (2) · Idiopathic Hypersomnia (1)
Caffeine (1) · Gemfibrozil (1) · mitiglinide (1)
Puerto Rico (1) · Switzerland (1) · United States (1)
Erin Nulf, RN, BSN (1) · Paul Martha, MD (1)